News
1 October 2026
Fonko Strengthens Indonesia’s Oncology Industry Capacity
JAKARTA — PT Fonko International Pharmaceuticals has recorded several key milestones in the development of oncology drug manufacturing in Indonesia. These achievements include securing European Union Good Manufacturing Practice (EU GMP) certification in 2025, developing a range of "first copy" products for cancer therapy, and obtaining halal certification for its…
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
25 May 2020
STIMUNO Wins 11th Top Brand Award
STIMUNO received another Top Brand Award 2020 for 11 consecutive years. Launched in 1999, the brand has achieved numerous awards and achievements during its 20-year journey as an immunomodulator in Indonesia, as reported in Marketing Magazine 06/XX/June 2020. Commercial Director of PT Dexa Medica, V. Hery Sutanto said that STIMUNO…
25 May 2020
DLBS Executive Director Listed as SINTA 2020 Best Researcher
Executive Director of Dexa Laboratories of Biomolecular Sciences (DLBS), Dr. Raymond R. Tjandrawinata has been named the Best Researcher in the Science and Technology Index (SINTA) 2020 by scoring very high cumulative Google Scholar H-index. The total number of researchers who work as lecturers and are registered at SINTA is…
8 February 2020
Dharma Dexa Successfully Holds Happy Parents Happy Kids Seminar
Dexa Group through Dharma Dexa, which cares about the importance of parenting, especially during the pandemic, has held the Happy Parents, Happy Kids program that has been running since December 2020 and continued on February 6, 2021. The Happy Parents Happy Kids program is held for all families of Dexa…
16 December 2019
Dexa Group Awarded Rintisan Teknologi Industri Award by Ministry of Industry Indonesia
Dexa Group received two prestigious awards from the Ministry of Industry Indonesia, which are the Green Industry Award 2019 through PT Ferron Par Pharmaceuticals and the Technology Pioneer Award 2019 through PT Dexa Medica. The awards were given for the company’s commitment to increasing industry competitiveness around research development and…
16 December 2019
Dexa Group Awarded as The Green Industry by Ministry of Industry Indonesia
Dexa Group received two prestigious awards from the Ministry of Industry Indonesia, which are the Green Industry Award 2019 through PT Ferron Par Pharmaceuticals and the Technology Pioneer Award 2019 through PT Dexa Medica. The awards were given for the company’s commitment to increasing industry competitiveness around research development and…
16 December 2019
Dexa Group CEO Named as the Most Admired CEO 2019
Dexa Group CEO, Ferry Soetikno has been named as the Most Admired CEO 2019 in the Excellent Leadership Pharmaceutical Market category by WartaEkonomi.co.id Research and Consulting. This award acknowledges the CEO's role in leading a company and constantly bringing something new to the business industry in Indonesia. The Most Admired…
10 December 2019
Indonesia IndigenousModern Medicine, Redacid Obtained Phytopharmaceutical NIE
Indonesia Indigenous Modern Medicine (OMAI) from Dexa Group, REDACID obtained its Marketing Authorization Number (NIE) as a phytopharmaceutical product from the National Agency of Drug and Food Control (BPOM). This product license is in line with BPOM’s efforts to support the downstreaming of drugs and food research and development through…
